INHIBITION OF HCV REPLICATION BY CCR5 BLOCKADE WITH CENICRIVIROC AND MARAVIROC

被引：1
|
作者：
Sherman, K. E. [1 ]
Kong, L. [1 ]
Blackard, J. T. [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Digest Dis, Cincinnati, OH USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31109-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0906
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [21] The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitis
    Reuveni, D.
    Leung, P.
    Vig, P.
    Shibolet, O.
    Gershwin, E. M.
    Zigmond, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S75 - S76
  • [22] The Expanding Therapeutic Perspective of CCR5 Blockade
    Vangelista, Luca
    Vento, Sandro
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [23] Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients
    Haim-Boukobza, Stephanie
    Balabanian, Karl
    Teicher, Elina
    Bourgeade, Marion
    Perlemuter, Gabriel
    Roque-Afonso, Anne-Marie
    Duclos-Vallee, Jean-Charles
    JOURNAL OF HEPATOLOGY, 2013, 59 (03) : 613 - 615
  • [24] Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc
    Rossi, Raffaella
    Lichtner, Miriam
    Sauzullo, Ilaria
    Mengoni, Fabio
    Marocco, Raffaella
    Massetti, Anna Paola
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (05) : E13 - E14
  • [25] Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection
    Van Der Ryst, Elna
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [26] CCR2/CCR5 antagonist cenicriviroc reduces colonic inflammation and fibrosis in experimental colitis
    Song, Xin
    Jiang, Chensheng
    Yu, Mengli
    Lu, Chao
    He, Xinjue
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1597 - 1605
  • [27] A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics
    Karris, Maile Y.
    Umlauf, Anya
    Vaida, Florin
    Richman, Douglas
    Little, Susan
    Smith, Davey
    MEDICINE, 2016, 95 (44)
  • [28] Effect of CCR5Δ32 on HCV infection.
    Promrat, K
    McDermott, DH
    Gonzalez, CM
    Lessie, MD
    Merrell, MN
    Koziol, D
    Ghany, M
    Park, Y
    Alter, HJ
    Hoofnagle, JH
    Murphy, PM
    Liang, TJ
    HEPATOLOGY, 2001, 34 (04) : 230A - 230A
  • [29] Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells
    Madan, Upasna
    Verma, Bhawna
    Awasthi, Amit
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (07)
  • [30] In vitro effects of the CCR5 inhibitor maraviroc on human T cell function
    Arberas, H.
    Guardo, A. C.
    Bargallo, M. E.
    Maleno, M. J.
    Calvo, M.
    Blanco, J. L.
    Garcia, F.
    Gatell, J. M.
    Plana, M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 577 - 586
12345